EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions

Yefang Zhao, Bingjie Wang, Xujing Wei, Dengxiang Liu, Ruiping Wang, Huashu Ma, Zongxu Qiao, Nana Kong, Jinhui Feng, Dan Cui, Shaoke Hou, Hongzhen Zhang iD

Mediators of Inflammation · 2025

DOI: 10.1155/mi/3010379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Yefang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Gastrointestinal Microbiome, Dysbiosis, Probiotics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Medical Science Research Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to investigate the impact of fecal microbiota transplantation (FMT) on gut microbiota composition and serum inflammatory factors in a murine model.

Methods

Female C57BL/6J mice ( n = 60) were divided into four groups: control (Con), negative (Neg), normal transplantation (NT), and preeclampsia transplantation (PET). The Con group received no treatment, while the Neg, NT, and PET groups were administered a triple antibiotic regimen (ampicillin, neomycin sulfate, and metronidazole) for 14 days to deplete gut microbiota. Following antibiotic treatment, FMT was performed: the NT group received fecal microbiota from healthy pregnant women and the PET group received microbiota from severe preeclampsia patients. Fecal samples and serum were collected for 16S rRNA sequencing and inflammatory factor analysis, respectively.

Results

Significant differences in gut microbial composition were observed between the PET group and other groups, with enriched taxa such as Coprococcus , Bacillales , and Staphylococcus in the PET group. Conversely, taxa such as Helicobacter and Klebsiella were more abundant in the fecal microbiota of mice in the NT group. Furthermore, serum levels of lipopolysaccharide (LPS), tumor necrosis factor‐alpha (TNF‐α), and interleukin‐6 (IL‐6) were markedly elevated in the PET group compared to the control, negative, and NT groups. Transplantation with fecal bacteria from preeclampsia patients leads to significant alterations in gut microbiota composition and increased serum inflammatory factors levels in mice.

Conclusion

These findings provide insights into the relationship between gut microbiota and inflammatory processes in preeclampsia and underscore the potential therapeutic implications of FMT in modulating gut microbiota dysbiosis and inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaGastrointestinal MicrobiomeDysbiosisProbioticsFemaleAnimalsPregnancyMiceMice, Inbred C57BLFecal Microbiota TransplantationHumansTumor Necrosis Factor-alphaBiomarkersFecesInterleukin-6RNA, Ribosomal, 16SAnti-Bacterial AgentsLipopolysaccharides

Stichwörter der Autor:innen

fecal microbiota transplantationgut microbiotainflammatory factorintestinal barrierpreeclampsia

Substanzen

Tumor Necrosis Factor-alphaBiomarkersInterleukin-6RNA, Ribosomal, 16SAnti-Bacterial AgentsLipopolysaccharides

Autor:innen und Institutionen

  • Department of Obstetrics, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.
  • Department of Proctology, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.
  • Department of Obstetrics and Gynecology, First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Cancer Laboratory, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.

ORCID-Profile: Hongzhen Zhang

Förderung

  • Hebei Province Medical Science Research Key Project

Zitieren

APA

Zhao, Y., Wang, B., Wei, X., Liu, D., Wang, R., Ma, H., Qiao, Z., Kong, N., Feng, J., Cui, D., Hou, S., & Zhang, H. (2025). Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions. Mediators of Inflammation. https://doi.org/10.1155/mi/3010379

Vancouver

Zhao Y, Wang B, Wei X, Liu D, Wang R, Ma H, et al. Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions. Mediators of Inflammation. 2025. doi:10.1155/mi/3010379

BibTeX
@article{Zhao2025,
  author = {Zhao, Yefang and Wang, Bingjie and Wei, Xujing and Liu, Dengxiang and Wang, Ruiping and Ma, Huashu and Qiao, Zongxu and Kong, Nana and Feng, Jinhui and Cui, Dan and Hou, Shaoke and Zhang, Hongzhen},
  title = {Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions},
  journal = {Mediators of Inflammation},
  year = {2025},
  doi = {10.1155/mi/3010379}
}
Kostenlos starten →